The roles of ERAP1 and ERAP2 in autoimmunity and cancer immunity: New insights and perspective
Farhad Babaie(Urmia University), Hamed Mohammadi(Tehran University of Medical Sciences), Soraya Salimi(Urmia University), Saeed Aslani(Tehran University of Medical Sciences), Gholamreza Azizi(Jefferson Hospital for Neuroscience), Maryam Hemmatzadeh(Tabriz University of Medical Sciences), Farhad Jadidi‐Niaragh(Tabriz University of Medical Sciences), Ramin Hosseinzadeh(Tehran University of Medical Sciences), Narges Seyfizadeh(Heidelberg University), Mehrdad Ebrazeh(Islamic Azad University, Bonab Branch)
Cited by 67
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
|International Immunopharmacology|2022|384
Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment
|Frontiers in Immunology|2022|363
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
|Scandinavian Journal of Immunology|2020|339
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312